Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors

NANot yet recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

December 31, 2026

Conditions
ImmunotherapyChemotherapy
Interventions
DIETARY_SUPPLEMENT

oral Lactobacillus johnsonii (1×10¹¹ CFU, twice daily)

Lactobacillus johnsonii, as a member of gut probiotics, has recently gained attention for its potential role in tumor immunotherapy due to its ability to modulate the immune system and maintain gut microbiota balance. Below is a summary of its possible mechanisms and applications: 1.Modulating Gut Microbiota and Immune Microenvironment. 2.Direct or Indirect Activation of Anti-Tumor Immunity. 3.Enhancing Efficacy of Immune Checkpoint Inhibitors (ICIs) . 4.Anti-Tumor Effects of Microbial Metabolites. 5.Preclinical and Clinical Research Progress.

DIETARY_SUPPLEMENT

Placebo

oral take placebo twice a day

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER